We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Hetlioz

News List

FDA Approves HETLIOZ for Nighttime Sleep Disturbances in Smith-Magenis Syndrome americanpharmaceuticalreview
December 22, 2020
Vanda Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) has approved HETLIOZ® (tasimelteon) capsule and liquid formulations for the treatment of adults and children, respectively, with nighttime sleep disturbances associated with ...
Vanda Announces Positive Study Results for Hetlioz americanpharmaceuticalreview
December 11, 2018
Vanda announced Hetlioz (tasimelteon) improved sleep quality and increased sleep duration in patients with Smith-Magenis Syndrome (SMS) in a pivotal placebo controlled clinical study....
Vanda Pharmaceuticals’ Hetlioz Shows Promise for Treating Jet Lag biospace
March 06, 2018
Vanda Pharmaceuticals, Inc., based in Washington, D.C., announced positive results from its JET8 Phase III clinical trial of Hetlioz for jet lag disorder.